Nanobiotix S.A.

NBTX - CIK 0001760854

Market cap$1.60 B

Rank#2275

SEC filings295

Nanobiotix S.A. trades as NBTX and has a market capitalization of $1.60 B, making it the #2275 largest US-listed company by market value. This page tracks Nanobiotix S.A. through 295 SEC filings, with financial statements and metrics updated as new reports are filed.

Latest filings

Filing	Type	Filed
6-K	-	2026-05-26
6-K	-	2026-05-26
6-K	-	2026-05-22
Free writing prospectus	FWP	2026-05-22
Prospectus supplement	424B5	2026-05-22
6-K	-	2026-05-21
6-K	-	2026-05-21
6-K	-	2026-05-21

Browse the full filing history (295 filings)

Similar companies

The largest companies sharing Nanobiotix S.A.'s SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T NBTX vs LLY

JNJJohnson & Johnson$573.98 B NBTX vs JNJ

ABBVAbbVie Inc.$399.47 B NBTX vs ABBV

MRKMerck & Co., Inc.$293.16 B NBTX vs MRK

AZNAstraZeneca PLC$286.27 B NBTX vs AZN

Frequently asked questions

What is Nanobiotix S.A.'s market cap?

Nanobiotix S.A. (NBTX) has a market capitalization of $1.60 B as of 2026-06-10, ranking #2275 among US-listed companies.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.